LeadingBiotech: Boston CEO is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Douglas Eby
Founder and CEO at Cambridge Science


Mr. Eby is the Founder and CEO of the Cambridge Science Corporation, a life sciences operating company incubating in-house technologies, and providing capital to external early stage biotechnology research and development being conducted both in academic labs and startups. He is a Co-Founder and CEO of Vivtex, a biotech company commercializing transformative drug formulation and delivery technology developed in the Langer Lab at MIT. Mr. Eby is a past Harvard Fellow in the University’s Advanced Leadership Initiative and a current Senior Fellow at Harvard Law School, where he is leading the Innovative Funding Models for Translational Research Project at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics. He has served as a director of several public companies including the Markel Corporation, Level 3 Communications, and CBRE Realty Finance, and as an advisory director of Sallie Mae. Mr. Eby has served on the boards on numerous nonprofits including Suburban Hospital – John Hopkins Medicine, where he was chairman of the investment committee.

Douglas Eby's Network

Agenda Sessions

  • Moderated Keynote: Strategic Partnerships & Medical Research Funding

    , 2:30pm